Company / Current Liabilities
Veracyte, Inc. Current Liabilities History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$59.9M
FY2025
5-year range
$59.9M / $78.6M
FY2021-FY2025
Trend
-23.8%
vs FY2024
Sector context
#147 of 165
Health Care
What the data says
Veracyte, Inc.'s current liabilities of $60M is lower than 89% of companies in the Health Care sector (FY2025). Current Liabilities has fluctuated over the past 10 years, ranging from $12M in FY2016 to $79M in FY2024.
Based on SEC 10-K filings.
$60M in FY2025 with a 5-year CAGR of +29.0%.
Improved from $61M to $60M over the past 2 years.
Health Care sector context is included.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- -1.4%
- 5-Year CAGR
- +29.0%
- 10-Year CAGR
- -
Sector benchmark
Top 11% in Health CareTop 11% of 165This company $59.9M Sector average $4.4B
▼
-98.6% below sector average
Key checks
Key Insights
- 5-year CAGR of +29.0%, indicating consistent growth.
- In FY2025, current liabilities decreased 23.8% year-over-year.
- Ranks #147 out of 165 companies in the Health Care sector.
- Peak current liabilities was recorded in FY2024.
Company context
Key Data Points
- Altman Z-Score 6.19 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $59.9M | -23.8% |
| FY2024 | $78.6M | +28.4% |
| FY2023 | $61.2M | -2.2% |
| FY2022 | $62.6M | -2.4% |
| FY2021 | $64.2M | +282.3% |
| FY2020 | $16.8M | -3.9% |
| FY2019 | $17.5M | +33.8% |
| FY2018 | $13.1M | +8.6% |
| FY2017 | $12.0M | +4.3% |
| FY2016 | $11.5M | -21.7% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026